Clinical Trials on Bartholin Gland Transitional Cell Carcinoma
Total 15620 results
-
Case Comprehensive Cancer CenterPfizerTerminatedRecurrent Bladder Cancer | Transitional Cell Carcinoma of the BladderUnited States
-
Pierre Fabre MedicamentBristol-Myers SquibbCompletedBladder Cancer | Bladder Neoplasms | Transitional Cell Carcinoma of the Urothelial TractCanada
-
European Organisation for Research and Treatment...National Cancer Institute (NCI); NCIC Clinical Trials Group; Institute of Cancer... and other collaboratorsCompletedStage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder
-
Emory UniversityTerminatedBladder Cancer | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Squamous Cell Carcinoma of the BladderUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Endometrial Adenocarcinoma | Endometrial Transitional Cell Carcinoma | Endometrial Mucinous Adenocarcinoma | Endometrial Mixed Adenocarcinoma | Endometrial...United States
-
Association Pour La Recherche des Thérapeutiques...Roche Pharma AGCompletedRecurrent Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the BladderFrance, Belgium
-
Eli Lilly and CompanyCompletedUrologic Neoplasms | Carcinoma, Transitional CellJapan
-
Tulane University Health Sciences CenterCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
Altor BioScienceNational Cancer Institute (NCI)UnknownTransitional Cell Carcinoma of Bladder | Urethra Cancer | Ureter Cancer | Malignant Tumor of Renal PelvisUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Endometrial Adenocarcinoma | Endometrial Transitional Cell Carcinoma | Endometrial Mucinous Adenocarcinoma | Endometrial Mixed Adenocarcinoma | Endometrial...United States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
Five Prime Therapeutics, Inc.CompletedGastric Cancer | Advanced Solid Tumors | Transitional Cell Carcinoma of the BladderKorea, Republic of, United States, Taiwan
-
Bristol-Myers SquibbCompletedSoft Tissue Sarcoma | Transitional Cell Carcinoma | Advanced Non-small Cell Lung Cancer | Gastric/Esophageal Adenocarcinoma | Pancreatic Cancer Including Ampulla of VaterUnited States, Argentina, Germany, Belgium, Canada, Poland, Netherlands, United Kingdom, France
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
Spanish Oncology Genito-Urinary GroupCompletedCarcinoma, Transitional CellSpain
-
AmgenUnknownBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
Institut CurieCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterFrance
-
Sichuan Provincial People's HospitalRecruiting
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingUrothelial Carcinoma
-
Abbisko Therapeutics Co, LtdRecruitingUrothelial CarcinomaChina
-
Erasmus Medical CenterMerck KGaA, Darmstadt, GermanyRecruitingUrothelial CarcinomaNetherlands
-
Matteo SantoniRecruiting
-
Jun GuoNot yet recruiting
-
South Metropolitan Health ServiceTelix Pharmaceuticals (Innovations) Pty LimitedCompletedUrothelial CarcinomaAustralia
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Completed
-
Memorial Sloan Kettering Cancer CenterMayo Clinic; Hartford HospitalActive, not recruitingUrothelial CarcinomaUnited States
-
University of WashingtonActive, not recruitingUrothelial CarcinomaUnited States
-
University of Michigan Rogel Cancer CenterCompletedUrothelial CarcinomaUnited States
-
Centre Hospitalier Universitaire, AmiensCompletedUrothelial Carcinoma
-
Hoffmann-La RocheCompletedUrothelial CarcinomaArgentina
-
Yousef ZakhariaPfizer; University of IowaActive, not recruitingUrothelial CarcinomaUnited States
-
Germans Trias i Pujol HospitalFundació Institut Germans Trias i Pujol; Spanish Clinical Research Network... and other collaboratorsCompletedUrothelial CarcinomaSpain
-
University of Michigan Rogel Cancer CenterTerminatedUrothelial CarcinomaUnited States
-
Peking University Cancer Hospital & InstituteUnknown
-
Genentech, Inc.TerminatedUrothelial CarcinomaKorea, Republic of, United States, Canada, United Kingdom, Belgium
-
Hoosier Cancer Research NetworkNovartis PharmaceuticalsWithdrawnUrothelial Carcinoma
-
Asan Medical CenterCompletedUrothelial CarcinomaKorea, Republic of
-
National Taiwan University HospitalUnknown
-
National Cancer Institute (NCI)CompletedRecurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Transitional Cell Carcinoma of the Bladder | Ureter Cancer | Recurrent Urethral CancerUnited States
-
National Cancer Institute (NCI)AstraZeneca; NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian... and other conditionsUnited States, Canada, Korea, Republic of, Japan
-
Hull University Teaching Hospitals NHS TrustC-Term Diagnostics Ltd; Hull York Medical SchoolCompletedTransitional Cell CarcinomaUnited Kingdom
-
Shandong New Time Pharmaceutical Co., LTDUnknownLocally Advanced or Metastatic Urothelial Cell Carcinoma
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Endometrial Adenocarcinoma | Endometrial Transitional Cell Carcinoma | Endometrial Mucinous Adenocarcinoma | Endometrial Squamous Cell Carcinoma | Malignant Uterine Corpus Mixed Epithelial and Mesenchymal NeoplasmUnited States
-
All India Institute of Medical Sciences, New DelhiCompletedRenal Cell Carcinoma | Transitional Cell Carcinoma | AML | Renal CystsIndia
-
University of Michigan Rogel Cancer CenterNot yet recruitingUrothelial CarcinomaUnited States
-
Peking University First HospitalRecruiting
-
Peking University Cancer Hospital & InstituteRecruiting